Skip to main content
. 2016 Dec 23;8(4):6446–6460. doi: 10.18632/oncotarget.14119

Table 3. β-blocker usage identified in the retrospective study.

β-Blocker # Patients Dose Range Selectivity
Carvedilol 9 2.12–25 mg daily Non-selective
Propranolol Sotalol 1 40 mg daily Non-selective
Timolol 1 160 mg daily Non-selective
Acebutolol 1 0.25%, 2 drops/day Non-selective
Atenolol 1 50 mg daily β1-AR
Bisoprolol 12 25–100 mg daily β1-AR
Metoprolol 1 6.25 mg daily β1-AR
28 25–100 mg daily β1-AR